Collegium Pharmaceutical, Inc. (COLL)

47.74 +2.20 (+4.83%) USD  |  NASDAQ  |  Jan 12, 12:02
More

Collegium Pharmaceutical Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Intuitive Surgical, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Altimmune, Inc. Upgrade